{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:02:56Z","timestamp":1789124576671,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005304","name":"Agence Nationale pour le D?veloppement de la Recherche en Sant?","doi-asserted-by":"publisher","award":["43-ANDRS-2011"],"award-info":[{"award-number":["43-ANDRS-2011"]}],"id":[{"id":"10.13039\/501100005304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10787-019-00567-8","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T05:56:14Z","timestamp":1549346174000},"page":"1113-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Auto-immunity profile evaluation during different clinical manifestations of Beh\u00e7et disease in Algerian patients: effect of corticosteroid treatment"],"prefix":"10.1007","volume":"27","author":[{"given":"Fatmazohra","family":"Djaballah-Ider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Djaballah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Djeraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafia","family":"Touil-Boukoffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"issue":"5","key":"567_CR1","first-page":"37","volume":"78","author":"ZS Alekberova","year":"2000","unstructured":"Alekberova ZS, Prokaeva TB, Reshetniak TM et al (2000) Antiphospholipid anti-bodies in Behcet\u2019s disease. Klin Med 78(5):37\u201338","journal-title":"Klin Med"},{"issue":"4","key":"567_CR2","first-page":"241","volume":"9","author":"MR Ataollahi","year":"2012","unstructured":"Ataollahi MR, Aflaki E, Nazarinia MA et al (2012) anti-cardiolipin and anti-neutrophil cytoplasmic anti-bodies in Iranian patients with Behcet\u2019s disease. Iran J Immunol 9(4):241\u2013247","journal-title":"Iran J Immunol"},{"issue":"1","key":"567_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","volume":"12","author":"Y Bardak","year":"2004","unstructured":"Bardak Y, Arido\u011fan BC (2004) The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et\u2019s disease with ocular involvement. Ocul Immunol Inflamm 12(1):53\u201358","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"567_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jbspin.2010.02.022","volume":"77","author":"P Caramaschi","year":"2010","unstructured":"Caramaschi P, Poli G, Bonora A et al (2010) A study on thrombophilic factors in Italian Behcet\u2019s patients. Joint Bone Spine 77(4):330\u2013334. \nhttps:\/\/doi.org\/10.1016\/j.jbspin.2010.02.022","journal-title":"Joint Bone Spine"},{"issue":"5","key":"567_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/bjd.12128","volume":"168","author":"SB Cho","year":"2013","unstructured":"Cho SB, Zheng Z, Ahn KJ et al (2013) Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2\/B1 in Patients with Beh\u00e7et disease. Br J Dermatol 168(5):977\u2013983. \nhttps:\/\/doi.org\/10.1111\/bjd.12128","journal-title":"Br J Dermatol"},{"issue":"1","key":"567_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/BOR.0000000000000451","volume":"30","author":"P Coit","year":"2018","unstructured":"Coit P, Direskeneli H, Sawalha AH (2018) An update on the role of epigenetics in systemic vasculitis. Curr Opin Rheumatol 30(1):4\u201315. \nhttps:\/\/doi.org\/10.1097\/BOR.0000000000000451","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"567_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","volume":"29","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet\u2019s disease: from east to west. Clin Rheumatol 29(8):823\u2013833. \nhttps:\/\/doi.org\/10.1007\/s10067-010-1430-6","journal-title":"Clin Rheumatol"},{"issue":"12","key":"567_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H (2006) auto-immunity vs auto-inflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatology 45(12):1461\u20131465. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kel329","journal-title":"Rheumatology"},{"issue":"3","key":"567_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/09273948.2012.671882","volume":"20","author":"F Djaballah-Ider","year":"2012","unstructured":"Djaballah-Ider F, Chaib S, Belguendouz H et al (2012) T cells activation and interferon-\u03b3\/nitric oxide production during Beh\u00e7et disease: a study in Algerian patients. Ocul Immunol Inflamm 20(3):215\u2013217. \nhttps:\/\/doi.org\/10.3109\/09273948.2012.671882","journal-title":"Ocul Immunol Inflamm"},{"key":"567_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-018-0472-2","author":"F Djaballah-Ider","year":"2018","unstructured":"Djaballah-Ider F, Djeraba Z, Chemli M et al (2018) Influence of corticosteroid therapy on IL-18 and nitric oxide production during Beh\u00e7et\u2019s disease. Inflammopharmacology. \nhttps:\/\/doi.org\/10.1007\/s10787-018-0472-2","journal-title":"Inflammopharmacology"},{"issue":"4","key":"567_CR11","first-page":"826","volume":"26","author":"E Ek\u015fioglu-Demiralp","year":"1999","unstructured":"Ek\u015fioglu-Demiralp E, Kibaroglu A, Direskeneli H et al (1999) Phenotypic characteristics of B cells in Beh\u00e7et\u2019s disease: increased activity in B cell subsets. J Rheumatol 26(4):826\u2013832","journal-title":"J Rheumatol"},{"issue":"5","key":"567_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00296-001-0157-8","volume":"21","author":"EM El-Ageb","year":"2002","unstructured":"El-Ageb EM, Al-Maini MH, Al-Shukaily AK et al (2002) Clinical features of Beh\u00e7et\u2019s disease in patients in the sultanate of Oman; the significance of antiphospholipid anti-bodies? Rheumatol Int 21(5):176\u2013181","journal-title":"Rheumatol Int"},{"issue":"5","key":"567_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10072-017-2856-2","volume":"38","author":"E Erda\u011f","year":"2017","unstructured":"Erda\u011f E, \u015eahin C, K\u00fc\u00e7\u00fckali C\u0130 et al (2017) Effects of in vivo and in vitro administration of neuro-Behcet\u2019s disease IgG. Neurol Sci 38(5):833\u2013843. \nhttps:\/\/doi.org\/10.1007\/s10072-017-2856-2","journal-title":"Neurol Sci"},{"issue":"4","key":"567_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.sjopt.2015.05.003","volume":"29","author":"S Erdo\u011fan","year":"2015","unstructured":"Erdo\u011fan S, Sorgun MH, Yal\u00e7\u0131nda\u011f N et al (2015) Bilateral optic neuritis in a patient with Beh\u00e7et\u2019s disease who respond to therapeutic plasma exchange. Saudi J Ophthalmol 29(4):298\u2013300. \nhttps:\/\/doi.org\/10.1016\/j.sjopt.2015.05.003","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"567_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0038-1656368","volume":"68","author":"M Galli","year":"1992","unstructured":"Galli M, Comfurius P, Barbui T et al (1992) Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin anti-bodies. Thromb Haemost 68(3):297\u2013300","journal-title":"Thromb Haemost"},{"key":"567_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2017.02.005","author":"AA Garcia-Rivero","year":"2017","unstructured":"Garcia-Rivero AA, Gonzalez-Argote J, Mart\u00ednez Larrarte JP et al (2017) Neuroimmunological response in neuro-Beh\u00e7et\u2019s. Reumatol Clin. \nhttps:\/\/doi.org\/10.1016\/j.reuma.2017.02.005","journal-title":"Reumatol Clin"},{"issue":"2","key":"567_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ajt.12984","volume":"15","author":"V Gorbacheva","year":"2015","unstructured":"Gorbacheva V, Ayasoufi K, Fan R et al (2015) B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. Am J Transpl 15(2):346\u2013357. \nhttps:\/\/doi.org\/10.1111\/ajt.12984","journal-title":"Am J Transpl"},{"issue":"2","key":"567_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0181-5512(06)73762-7","volume":"29","author":"H Guenane","year":"2006","unstructured":"Guenane H, Hartani D, Chachoua L et al (2006) Production of Th1\/Th2 cytokines and nitric oxide in Beh\u00e7et\u2019s uveitis and idiopathic uveitis. J Fr Ophtalmol 29(2):146\u2013152","journal-title":"J Fr Ophtalmol"},{"issue":"4","key":"567_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A G\u00fcl","year":"2015","unstructured":"G\u00fcl A (2015) Pathogenesis of Beh\u00e7et\u2019s disease: auto-inflammatory features and beyond. Semin Immunopathol 37(4):413\u2013418. \nhttps:\/\/doi.org\/10.1007\/s00281-015-0502-8","journal-title":"Semin Immunopathol"},{"issue":"4","key":"567_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F et al (2002) Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31(4):205\u2013210","journal-title":"Scand J Rheumatol"},{"issue":"4 Suppl 50","key":"567_CR21","first-page":"S64","volume":"26","author":"K Hamzaoui","year":"2008","unstructured":"Hamzaoui K, Houman H, Ben Dhifallah I et al (2008) Serum BAFF levels and skin MRNA expression in patients with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 26(4 Suppl 50):S64\u201371","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"567_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12882-017-0451-7","volume":"18","author":"T Higashihara","year":"2017","unstructured":"Higashihara T, Okada A, Kusano T et al (2017) A novel case of renal pathergy reaction in a Beh\u00e7et\u2019s disease patient complicated by IgA vasculitis. BMC Nephrol 18(1):40. \nhttps:\/\/doi.org\/10.1186\/s12882-017-0451-7","journal-title":"BMC Nephrol"},{"issue":"4","key":"567_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1468-3083.2005.01193.x","volume":"19","author":"L Kandolf-Sekulovic","year":"2005","unstructured":"Kandolf-Sekulovic L, Pavlovic MD, Glisic B et al (2005) Adamantiades-Beh\u00e7et\u2019s disease, deep venous thrombosis and anticardiolipin anti-bodies: report of two cases. J Eur Acad Dermatol Venereol 19(4):484\u2013486. \nhttps:\/\/doi.org\/10.1111\/j.1468-3083.2005.01193.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"567_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3346\/jkms.1998.13.4.400","volume":"13","author":"HJ Kang","year":"1998","unstructured":"Kang HJ, Lee YW, Han SH et al (1998) Anticardiolipin and anti-beta2-glycoprotein I anti-bodies in Behcet\u2019s disease. J Korean Med Sci 13(4):400\u2013404. \nhttps:\/\/doi.org\/10.3346\/jkms.1998.13.4.400","journal-title":"J Korean Med Sci"},{"issue":"6","key":"567_CR25","first-page":"67","volume":"35 Suppl 108","author":"SE Kang","year":"2017","unstructured":"Kang SE, Lee SJ, Lee JY et al (2017) Serum levels of IgG anti-bodies against alpha-enolase are increased in patients with Beh\u00e7et\u2019s disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein. Clin Exp Rheumatol 35 Suppl 108(6):67\u201374","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"567_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-010-1491-6","volume":"29","author":"VD Kapsimali","year":"2010","unstructured":"Kapsimali VD, Kanakis MA, Vaiopoulos GA et al (2010) Etiopathogenesis of Beh\u00e7et\u2019s disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29(11):1211\u20131216. \nhttps:\/\/doi.org\/10.1007\/s10067-010-1491-6","journal-title":"Clin Rheumatol"},{"issue":"2","key":"567_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/archdermatol.2008.570","volume":"145","author":"T Kawakami","year":"2009","unstructured":"Kawakami T, Yamazaki M, Mizoguchi M et al (2009) Antiphosphatidylserine-prothrombin complex anti-bodies in 3 patients with Beh\u00e7et disease involving superficial vein thrombophlebitis. Arch Dermatol 145(2):171\u2013175. \nhttps:\/\/doi.org\/10.1001\/archdermatol.2008.570","journal-title":"Arch Dermatol"},{"issue":"5","key":"567_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/09273948.2012.723112","volume":"20","author":"M Khairallah","year":"2012","unstructured":"Khairallah M, Accorinti M, Muccioli C et al (2012) Epidemiology of Beh\u00e7et disease. Ocul Immunol Inflamm 20(5):324\u2013335. \nhttps:\/\/doi.org\/10.3109\/09273948.2012.723112","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"567_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF (2008) B lymphocytes: how they develop and function. Blood 112(5):1570\u20131580. \nhttps:\/\/doi.org\/10.1182\/blood-2008-02-078071","journal-title":"Blood"},{"issue":"8","key":"567_CR30","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3(8):e297. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.0030297","journal-title":"PLoS Med"},{"issue":"4","key":"567_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","volume":"9","author":"C Mendoza-Pinto","year":"2010","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Jim\u00e9nez-Hern\u00e1ndez M et al (2010) Etiopathogenesis of Beh\u00e7et\u2019s disease. Auto-immun Rev 9(4):241\u2013245. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2009.10.005","journal-title":"Auto-immun Rev"},{"issue":"4","key":"567_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.arcmed.2005.03.019","volume":"36","author":"U Musabak","year":"2005","unstructured":"Musabak U, Baylan O, Cetin T et al (2005) Lipid profile and anticardiolipin anti-bodies in Behcet\u2019s disease. Arch Med Res 36(4):387\u2013392. \nhttps:\/\/doi.org\/10.1016\/j.arcmed.2005.03.019","journal-title":"Arch Med Res"},{"issue":"6","key":"567_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","volume":"26","author":"U Musabak","year":"2006","unstructured":"Musabak U, Pay S, Erdem H et al (2006) Serum interleukin-18 levels in patients with Beh\u00e7et\u2019s disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 26(6):545\u2013550. \nhttps:\/\/doi.org\/10.1007\/s00296-005-0029-8","journal-title":"Rheumatol Int"},{"key":"567_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H et al (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423\u2013474. \nhttps:\/\/doi.org\/10.1146\/annurev.immunol.19.1.423","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"567_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","volume":"100","author":"S Ohno","year":"1982","unstructured":"Ohno S, Ohguchi M, Hirose S et al (1982) Close association of HLA-Bw51 with Beh\u00e7et\u2019s disease. Arch Ophthalmol Chic Ill 1960 100(9):1455\u20131458","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"2","key":"567_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00296-013-2667-6","volume":"34","author":"SJ Park","year":"2014","unstructured":"Park SJ, Oh JY, Shin JI (2014) Could increased IgA induced by BAFF be the cause of IgA nephropathy development in Behcet\u2019s disease? Comment on: Behcet\u2019s disease and IgA nephropathy (Rheumatol Int. 2012 Jul; 32(7):2227\u20139). Rheumatol Int 34(2):283\u2013284. \nhttps:\/\/doi.org\/10.1007\/s00296-013-2667-6","journal-title":"Rheumatol Int"},{"issue":"2","key":"567_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02030089","volume":"8","author":"RM Pereira","year":"1989","unstructured":"Pereira RM, Gon\u00e7alves CR, Bueno C et al (1989) Anticardiolipin anti-bodies in Beh\u00e7et\u2019s syndrome: a predictor of a more severe disease. Clin Rheumatol 8(2):289\u2013291","journal-title":"Clin Rheumatol"},{"issue":"17","key":"567_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh\u00e7et\u2019s disease. N Engl J Med 341(17):1284\u20131291. \nhttps:\/\/doi.org\/10.1056\/NEJM199910213411707","journal-title":"N Engl J Med"},{"issue":"4","key":"567_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1590\/abd1806-4841.20177359","volume":"92","author":"MAR Scherrer","year":"2017","unstructured":"Scherrer MAR, Rocha VB, Garcia LC (2017) Beh\u00e7et\u2019s disease: review with emphasis on dermatological aspects. An Bras Dermatol 92(4):452\u2013464. \nhttps:\/\/doi.org\/10.1590\/abd1806-4841.20177359","journal-title":"An Bras Dermatol"},{"issue":"2","key":"567_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/art.1780290209","volume":"29","author":"N Suzuki","year":"1986","unstructured":"Suzuki N, Sakane T, Ueda Y, Tsunematsu T (1986) Abnormal B cell function in patients with Beh\u00e7et\u2019s disease. Arthritis Rheum 29(2):212\u2013219","journal-title":"Arthritis Rheum"},{"issue":"2","key":"567_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","volume":"40","author":"S Tokay","year":"2001","unstructured":"Tokay S, Direskeneli H, Yurdakul S et al (2001) Anticardiolipin anti-bodies in Beh\u00e7et\u2019s disease: a reassessment. Rheumatol Oxf Engl. 40(2):192\u2013195","journal-title":"Rheumatol Oxf Engl."},{"issue":"6","key":"567_CR42","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1073\/pnas.0712003105","volume":"105","author":"MD Trottier","year":"2008","unstructured":"Trottier MD, Newsted MM, King LE, Fraker PJ (2008) Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc Natl Acad Sci USA 105(6):2028\u20132033. \nhttps:\/\/doi.org\/10.1073\/pnas.0712003105","journal-title":"Proc Natl Acad Sci USA"},{"key":"567_CR43","first-page":"74","volume":"43","author":"U Tursen","year":"2009","unstructured":"Tursen U (2009) Activation markers in Behcet\u2019s disease. Urkderm Arch Turk Dermatol Venerol 43:74\u201386","journal-title":"Urkderm Arch Turk Dermatol Venerol"},{"issue":"6","key":"567_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/br.2017.996","volume":"7","author":"JY Yoon","year":"2017","unstructured":"Yoon JY, Lee Y, Yu SL et al (2017) Aberrant expression of interleukin-10 and activation-induced cytidine deaminase in B cells from patients with Beh\u00e7et\u2019s disease. Biomed Rep 7(6):520\u2013526. \nhttps:\/\/doi.org\/10.3892\/br.2017.996","journal-title":"Biomed Rep"},{"issue":"10","key":"567_CR45","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","volume":"11","author":"ZY Zhou","year":"2012","unstructured":"Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Behcet\u2019s disease. Auto-immun Rev 11(10):699\u2013704. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2011.12.005","journal-title":"Auto-immun Rev"},{"issue":"1","key":"567_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.17305\/bjbms.2011.2625","volume":"11","author":"M Zivkovic","year":"2011","unstructured":"Zivkovic M, Zlatanovic M, Zlatanovic G et al (2011) Anticardiolipin anti-bodies in patients with Behcet\u2019s disease. Bosn J Basic Med Sci 11(1):58\u201361","journal-title":"Bosn J Basic Med Sci"},{"issue":"3","key":"567_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2133.1993.tb00172.x","volume":"128","author":"CC Zouboulis","year":"1993","unstructured":"Zouboulis CC, B\u00fcttner P, Tebbe B et al (1993) Anticardiolipin anti-bodies in Adamantiades-Beh\u00e7et\u2019s disease. Br J Dermatol 128(3):281\u2013284","journal-title":"Br J Dermatol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-019-00567-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:27:54Z","timestamp":1580844474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-019-00567-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s10787-019-00567-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no conflicts of interest with regard to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript was approved by all co-authors. The local ethics committee \u201cAlgerian National Agency for Research in Health Sciences, ATRSS ex-ANDRS\u201d in compliance with Helsinki declaration has approved our study (Code number 43-ANDRS-2011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}